Development of a quantitative immunofluorescence assay for detection of Stenotrophomonas maltophilia antibodies in patients with cystic fibrosis.

[1]  N. Høiby,et al.  Chronic pulmonary infection with Stenotrophomonas maltophilia and lung function in patients with cystic fibrosis. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[2]  I. Crandall,et al.  Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. , 2011, American journal of respiratory and critical care medicine.

[3]  H. Kelly,et al.  Estimating sensitivity and specificity from positive predictive value, negative predictive value and prevalence: application to surveillance systems for hospital-acquired infections. , 2008, The Journal of hospital infection.

[4]  C. Meisner,et al.  Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients , 2007, Pediatric pulmonology.

[5]  D. Reinhardt,et al.  Diagnostic and prognostic value of serum antibodies against Pseudomonas aeruginosa in cystic fibrosis , 2006, Thorax.

[6]  A. Worster,et al.  Understanding receiver operating characteristic (ROC) curves. , 2006, CJEM.

[7]  T. Murphy,et al.  Systemic and mucosal antibody response to Moraxella catarrhalis after exacerbations of chronic obstructive pulmonary disease. , 2002, The Journal of infectious diseases.

[8]  J. Emerson,et al.  Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. , 2001, The Journal of infectious diseases.

[9]  N. Høiby,et al.  Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis , 1983, Infection and Immunity.